[go: up one dir, main page]

BRPI0819975A2 - Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo - Google Patents

Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo

Info

Publication number
BRPI0819975A2
BRPI0819975A2 BRPI0819975-2A BRPI0819975A BRPI0819975A2 BR PI0819975 A2 BRPI0819975 A2 BR PI0819975A2 BR PI0819975 A BRPI0819975 A BR PI0819975A BR PI0819975 A2 BRPI0819975 A2 BR PI0819975A2
Authority
BR
Brazil
Prior art keywords
regulatory
cells
reducing
effects
host disease
Prior art date
Application number
BRPI0819975-2A
Other languages
English (en)
Inventor
Tinghua Cao
Li Li
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Publication of BRPI0819975A2 publication Critical patent/BRPI0819975A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/001Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • A61K40/11T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/20Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22Immunosuppressive or immunotolerising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/418Antigens related to induction of tolerance to non-self
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0819975-2A 2007-11-30 2008-12-01 Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo BRPI0819975A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99130107P 2007-11-30 2007-11-30
US99234707P 2007-12-05 2007-12-05
PCT/US2008/085117 WO2009073599A1 (en) 2007-11-30 2008-12-01 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells

Publications (1)

Publication Number Publication Date
BRPI0819975A2 true BRPI0819975A2 (pt) 2015-06-16

Family

ID=40394411

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819975-2A BRPI0819975A2 (pt) 2007-11-30 2008-12-01 Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo

Country Status (9)

Country Link
US (1) US20090142317A1 (pt)
EP (1) EP2225365A1 (pt)
JP (1) JP2011505378A (pt)
KR (1) KR20100094997A (pt)
CN (1) CN101970643A (pt)
BR (1) BRPI0819975A2 (pt)
CA (1) CA2706458A1 (pt)
MX (1) MX2010005863A (pt)
WO (1) WO2009073599A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314443B2 (en) 2011-10-12 2016-04-19 National Center For Child Health And Development Enhancer of survival of transplanted organ
ES2675317T3 (es) * 2012-03-02 2018-07-10 The Regents Of The University Of California Expansión de linfocitos T reguladores reactivos a aloantígeno
WO2013168876A1 (ko) * 2012-05-11 2013-11-14 가톨릭대학교 산학협력단 이식 후 면역 상태를 모니터링 하는 키트 및 이를 이용한 면역 상태의 모니터링 방법
EP2873417B1 (en) 2012-07-13 2019-03-06 SBI Pharmaceuticals Co., Ltd. Immune tolerance inducer
WO2015014871A1 (en) * 2013-07-31 2015-02-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for identifying effector treg cells
CA2991077A1 (en) * 2015-07-03 2017-01-12 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for obtaining regulatory t cells and uses thereof
EP3216861A1 (en) * 2016-03-11 2017-09-13 Fropharm GmbH Immunoregulatory cells and methods for their production
CN107164324B (zh) * 2017-07-17 2020-03-27 沃昕生物科技(深圳)有限公司 一种脐血Treg细胞的体外扩增方法
SG11202010958YA (en) * 2018-06-14 2020-12-30 4D Pharma Res Ltd Compositions comprising bacterial strains
EP4041870A1 (en) * 2019-10-11 2022-08-17 Kuopio Center For Gene and Cell Therapy OY New regulatory macrophages and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050186207A1 (en) * 2004-01-08 2005-08-25 The Regents Of The University Of California Regulatory T cells suppress autoimmunity
EP1812563B1 (en) * 2004-10-29 2013-04-10 Benaroya Research Institute at Virginia Mason Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use
US8323969B2 (en) * 2007-05-18 2012-12-04 University Of Kansas Preparation of regulatory T cells using ICAM-1 co-stimulation

Also Published As

Publication number Publication date
CN101970643A (zh) 2011-02-09
WO2009073599A1 (en) 2009-06-11
MX2010005863A (es) 2010-06-23
JP2011505378A (ja) 2011-02-24
EP2225365A1 (en) 2010-09-08
US20090142317A1 (en) 2009-06-04
CA2706458A1 (en) 2009-06-11
KR20100094997A (ko) 2010-08-27

Similar Documents

Publication Publication Date Title
BRPI0819975A2 (pt) Processo para redução dos efeitos da doença de enxerto contra hospedeiros com o uso de células t reguladoras cd4+cd25+ expandidas ex vivo
MX379016B (es) Composiciones y metodos para tratar enfermedad de gaucher.
BRPI1009981A2 (pt) sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0815979A2 (pt) compostos e composições com inibidores de quinase, bem como uso dos mesmos
BRPI0817306A2 (pt) Implante para se ajustar dentro de um espaço intervertebral
CR11731A (es) Composiciones y procedimientos para su preparación y uso
EP3135247C0 (en) IMPLANTABLE TISSUE CONNECTOR
BRPI0719849A2 (pt) Método de imunização contra os quatro sorotipos da dengue
BRPI0817437A2 (pt) Implante cirúrgico com um recurso antirretrocesso
EP2222344A4 (en) VACCINATE COMPOSITIONS WITH DENDRITIC CELLS AND THEIR USE
ES2397671T8 (es) Procedimiento para preparar voriconazol
EP2173353A4 (en) Transplants
FR2913196B1 (fr) Implant oculaire accomodatif
EA201000202A1 (ru) Ингибиторы mpo для лечения болезни гентингтона и множественной системной атрофии
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
CL2008001323A1 (es) Compuestos derivados de triazolil aminopiridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0822946A2 (pt) Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BRPI0910446A2 (pt) rna modificado por lipídeo de flamento duplo tendo alto efeito de interferência de rna
EP2320729A4 (en) GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
DK2142032T3 (da) Kunstige negle indbefattende påføringsflig
BRPI1013051A2 (pt) composição imunogênica, uso de uma composição imunogênica, processo para fazer uma composição imunogênica, e, kit.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C12N 5/08; A61K 38/14.

Ipc: A61K 39/00 (2006.01), A61K 38/14 (2006.01)

Ipc: A61K 39/00 (2006.01), A61K 38/14 (2006.01)